Evidence map›Paper›PMID 40573355›Full record

Observational studyViruses2025

High Prevalence and Risk Factors for Infection with Human T-Lymphotropic Viruses 1 and 2 in the Municipality of Ananindeua, Pará, Northern Brazil.

Dara da Costa Soares, Felipe Teixeira Lopes, Gabriel Dos Santos Pereira Neto, Luciana Cristina Coelho Pantoja Santos, Aline Cecy Rocha Lima, Bruno Sarmento Botelho, Isabella Nogueira Abreu, Felipe Bonfim Freitas, Ricardo Ishak, Izaura Maria Vieira Cayres Vallinoto and 1 more

Abstract readObservational Study
In one paragraph

Observational study in Viruses, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Epidemiology and Clinical Outcomes of HTLV-1: A Comprehensive Narrative Review of Endemic and Nonendemic Regions.The Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale · 2026
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Dara da Costa SoaresLaboratory of Virology, Institute of Biological Sciences, Federal University of Pará, Belém 66075-110, Pará, Brazil.ORCID 0009-0008-3661-7121
Felipe Teixeira LopesLaboratory of Virology, Institute of Biological Sciences, Federal University of Pará, Belém 66075-110, Pará, Brazil.
Gabriel Dos Santos Pereira NetoLaboratory of Virology, Institute of Biological Sciences, Federal University of Pará, Belém 66075-110, Pará, Brazil.ORCID 0000-0002-7825-9384
Luciana Cristina Coelho Pantoja SantosLaboratory of Virology, Institute of Biological Sciences, Federal University of Pará, Belém 66075-110, Pará, Brazil.
Aline Cecy Rocha LimaLaboratory of Virology, Institute of Biological Sciences, Federal University of Pará, Belém 66075-110, Pará, Brazil.
Bruno Sarmento BotelhoLaboratory of Virology, Institute of Biological Sciences, Federal University of Pará, Belém 66075-110, Pará, Brazil.ORCID 0000-0001-9341-9350
Isabella Nogueira AbreuLaboratory of Virology, Institute of Biological Sciences, Federal University of Pará, Belém 66075-110, Pará, Brazil.
Felipe Bonfim FreitasVirology Section, Evandro Chagas Institute, Ananindeua 67030-000, Pará, Brazil.
Ricardo IshakLaboratory of Virology, Institute of Biological Sciences, Federal University of Pará, Belém 66075-110, Pará, Brazil.
Izaura Maria Vieira Cayres VallinotoLaboratory of Virology, Institute of Biological Sciences, Federal University of Pará, Belém 66075-110, Pará, Brazil.
Antonio Carlos Rosário VallinotoLaboratory of Virology, Institute of Biological Sciences, Federal University of Pará, Belém 66075-110, Pará, Brazil.ORCID 0000-0003-1135-6507

Funding

Conselho Nacional de Desenvolvimento Científico e Tecnológico 442522/2019-3; 302935/2021-5, and 402412/2021-4
6 · The paper itself

Abstract

This descriptive, observational, cross-sectional study evaluated HTLV-1 and HTLV-2 infections in Ananindeua, northern Brazil. Individuals were screened for anti-HTLV-1/2 using ELISA (Murex HTLV-I + II, DiaSorin). Reactive or indeterminate samples underwent confirmation via Western blot (HTLV Blot 2.4 kit, MP Diagnostics) and/or RT-qPCR. A questionnaire examined behavioral and risk factors for HTLV-1/2 infection. HTLV-positive individuals received counseling, nurse follow-up, and specialized medical care. Among the 228 individuals investigated, 6 (2.7%) were infected with HTLV-1: 4 men (66.67%) and 2 women (33.33%), aged 51-73 years. The only significant risk factor observed was blood transfusion. Additionally, 80 other individuals residing in the municipality of Ananindeua independently visited the laboratory for an HTLV-1/2 diagnosis. Among them, 23 were diagnosed with HTLV-1 infection, and 1 with HTLV-2. Among the 30 positive individuals, 80% were asymptomatic, while 20% exhibited clinical manifestations associated with HTLV infection, including HAM and Sézary syndrome. These results indicate a notable prevalence of HTLV-1 infection in the municipality of Ananindeua emphasizing the significance of diagnosing the infection to assess its prevalence across the country accurately.

Indexed as

HTLV-II InfectionsHTLV-I InfectionsHuman T-lymphotropic virus 1Human T-lymphotropic virus 2AdultAgedBrazilCross-Sectional StudiesFemaleHumansMaleMiddle AgedPrevalenceRisk FactorsYoung AdultAmazoniaAnanindeuaepidemiologyHTLV-1HTLV-2Pará

Identifiers

PMID40573355
PMCPMC12197338

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.